ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Maryland » Pulmonary Disease

Top Pulmonary Disease Prescribers in Maryland

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MALIK REHMAN MD

Pulmonary Disease

8,083

$528K

373
255 are 65+

21%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 61%

$65
Average prescription price

Avg: $190

ALLEN GILSON M.D.

Pulmonary Disease

5,091

$398K

268
215 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 61%

$78
Average prescription price

Avg: $190

JOSHUA AARON MD

Pulmonary Disease

3,909

$1.55M

401
243 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 61%

$397
Average prescription price

Avg: $190

IRA BERGER MD

Pulmonary Disease

3,326

$341K

304
283 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 61%

$103
Average prescription price

Avg: $190

IRVING MIZUS MD

Pulmonary Disease

3,213

$527K

202
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 61%

$164
Average prescription price

Avg: $190

PETER WISNIEWSKI MD

Pulmonary Disease

2,990

$326K

192
150 are 65+

18%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 61%

$109
Average prescription price

Avg: $190

NATASHA LAMMING-LEE M.D.,

Pulmonary Disease

2,800

$282K

178
127 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 61%

$101
Average prescription price

Avg: $190

WILLIAM RANDALL MD

Pulmonary Disease

2,613

$588K

416
376 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 61%

$225
Average prescription price

Avg: $190

IRNEST OSER MD

Pulmonary Disease

2,461

$336K

215
199 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 61%

$136
Average prescription price

Avg: $190

ZAHIR YOUSAF MD

Pulmonary Disease

2,409

$222K

175
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 61%

$92
Average prescription price

Avg: $190

LILA BAHADORI MD

Pulmonary Disease

2,379

$222K

206
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 61%

$93
Average prescription price

Avg: $190

IRA TAUBER MD

Pulmonary Disease

2,310

$236K

179
173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 61%

$102
Average prescription price

Avg: $190

JOHNY ALENCHERRY MD

Pulmonary Disease

2,075

$240K

379
267 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 61%

$115
Average prescription price

Avg: $190

SHEILA MAYO-OLANO M.D.

Pulmonary Disease

1,997

$508K

375
322 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

86%
prescriptions for brand name drugs

Avg: 61%

$255
Average prescription price

Avg: $190

MICHAEL LANSING M.D.

Pulmonary Disease

1,940

$482K

281
254 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 61%

$249
Average prescription price

Avg: $190

HOWARD FREELAND M.D.

Pulmonary Disease

1,933

$258K

358
301 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 61%

$134
Average prescription price

Avg: $190

ALAN CHANALES MD

Pulmonary Disease

1,918

$319K

164
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 61%

$166
Average prescription price

Avg: $190

MARSHA SEIDELMAN MD

Pulmonary Disease

1,800

$147K

139
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 61%

$82
Average prescription price

Avg: $190

VINCENT GIMINARO DO

Pulmonary Disease

1,788

$133K

157
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 61%

$75
Average prescription price

Avg: $190

LLOYD HALVORSON M.D.

Pulmonary Disease

1,753

$206K

174
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 61%

$117
Average prescription price

Avg: $190

BOYD SPRENKLE MD

Pulmonary Disease

1,725

$312K

224
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 61%

$181
Average prescription price

Avg: $190

PETER HAMM M.D.

Pulmonary Disease

1,699

$261K

251
236 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 61%

$153
Average prescription price

Avg: $190

PENELOPE SCOTT M.D.

Pulmonary Disease

1,622

$189K

144
111 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 61%

$116
Average prescription price

Avg: $190

LOUIS STEINBERG M.D.

Pulmonary Disease

1,617

$194K

122
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 61%

$120
Average prescription price

Avg: $190

ABDUL WAHEED MD

Pulmonary Disease

1,617

$215K

355
281 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 61%

$133
Average prescription price

Avg: $190

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank